| Universal influenza vaccine clinical trial begins enrolling volunteers Spectrum News: David Canaday, professor at the School of Medicine, discussed the effort, launched by the National Institute of Allergy and Infectious Diseases Vaccine Research Center, to enroll volunteers at Duke University for its Phase 1 trial of the mRNA-based vaccine—using the same technology as the COVID-19 vaccines. “This universal vaccine would get beyond that strain to strain change,” he said. “This vaccine would work on multiple, different strains even if there’s a change from season to season.” |
